跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,878 条关于
“ARO INHBE”
全部
6,878
临床试验
5,902
药物
488
机构
76
资讯
412
2年前
Arrowhead Pharmaceuticals Advances RNAi Therapies ARO-INHBE and ARO-ALK7 for Obesity Treatment
去年
Arrowhead Initiates Phase I/IIa Trial of RNAi Therapy ARO-INHBE for Obesity
8个月前
Arrowhead's Gene-Silencing Drugs Show Promise in Early Obesity Studies, Enhancing Weight Loss When Combined with Zepbound
9个月前
Arrowhead Pharmaceuticals Achieves FDA Approval for Rodemplo, Reports Strong Financial Turnaround
去年
Arrowhead Pharmaceuticals Launches First-in-Human Trial of ARO-ALK7 for Obesity Treatment
去年
Arrowhead Pharmaceuticals' FDA Acceptance of Plozasiran NDA Marks Milestone in RNAi Therapeutics
8个月前
Arrowhead Pharmaceuticals Reports Strong Q1 2026 Results with REDEMPLO Launch Success and Promising Obesity Pipeline Data
11个月前
Vial Initiates Phase 1 Trial of Novel INHBE siRNA Therapy for Obesity Treatment
去年
Rona Therapeutics Files IND for RN3161, Novel siRNA Targeting INHBE for Obesity Treatment
9个月前
Rona Therapeutics Completes First Cohort of Phase 1 Trial for Novel INHBE-Targeting siRNA Obesity Treatment
第 1 页,共 42 页
上一页
下一页